- 专利标题： Composition for preventing or treating muscle weakness-related diseases comprising sobrerol
-
申请号： US15758595申请日： 2016-09-09
-
公开(公告)号： US10765642B2公开(公告)日： 2020-09-08
- 发明人: Ki Sun Kwon , Jeongi Choi , Sung Sup Park , Sun Gun Chung , Eun Soo Kwon , Kwang-Pyo Lee , Seung Min Lee
- 申请人： KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY , SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
- 申请人地址： KR Daejeon KR Seoul
- 专利权人： KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY,SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
- 当前专利权人： KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY,SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
- 当前专利权人地址： KR Daejeon KR Seoul
- 代理机构： Sughrue Mion, PLLC
- 优先权： com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@589f1cd2
- 国际申请： PCT/KR2016/010209 WO 20160909
- 国际公布： WO2017/043935 WO 20170316
- 主分类号： A61K31/045
- IPC分类号： A61K31/045 ; A61K31/047 ; A23L33/10 ; A23K50/50 ; A23K20/105 ; C12N5/077
摘要：
The present invention relates to sobrerol or a pharmaceutically acceptable salt thereof, which can promote differentiation of myoblasts to form myotubes, thereby preventing muscle weakness and effectively improving muscle functions. Therefore, the pharmaceutical composition containing the same can be effectively used for preventing or treating muscle weakness related diseases.
公开/授权文献
信息查询
